ARE - Alexandria Real Estate: Emerging As A Strong Buy At Technical Support Junction

2023-12-05 02:41:52 ET

Summary

• Alexandria Real Estate Equities, Inc. reported increased total revenues and funds from operations in Q3 2023.
• The company showed resilience through robust operational metrics, including high tenant collection rates and solid occupancy rates.
• Technical analysis suggests a rebound in ARE's stock price from a significant long-term support level, indicating potential buying opportunities for investors.

Alexandria Real Estate Equities, Inc.'s ( ARE ) financial and operational performance in Q3 2023 is a multifaceted narrative of growth, resilience, and strategic foresight. The company witnessed a significant increase in total revenues compared to last year, marking a notable year-over-year increase. However, this period also saw a considerable decline in net income attributable to common stockholders. Despite this, ARE showed robust operational efficiency, evident in the increased funds from operations. This article examines ARE's financial stability and conducts a technical analysis of its stock price to determine its future trajectory and potential investment prospects. The study reveals that the stock price has corrected, reaching a significant long-term technical support junction. Price strength at these levels suggests potential buying opportunities for investors.

Financial Performance

ARE reported an increase in total revenues to $713.8 million from $659.9 million in Q3 2023. The year-to-date figures for 2023 reflect a total revenue of $2,128.5 million, showing a substantial increase from the $1,918.7 million reported in the same period in 2022. However, the net income attributable to common stockholders on a diluted basis dropped from $314.4 million in Q3 2022 to $21.9 million in Q3 2023. The year-to-date net income also dropped from $461.5 million in Q3 2022 to $184.4 million in Q3 2023. Nonetheless, the funds from operations attributable to common stockholders on a diluted basis have shown an increase, with $386.4 million for Q3 2023 and $1,142.5 million year-to-date, compared to $344.7 million and $1,008.1 million in the respective periods of the previous year.

The Q3 2023 earnings highlight solid operational metrics, including a tenant collection rate of 99.9%. The occupancy rate for ARE's North American properties was 93.7% as of September 30, 2023. Additionally, the adjusted EBITDA margin remained strong at 69%, and the weighted average remaining lease term was 8.9 years for the top 20 tenants and 7.0 years across all tenants. Regarding leasing activity, ARE reported a solid performance with 867,582 rentable square feet ((RSF)) leased during Q3 2023 and an even more significant year-to-date total of 3,416,335 RSF. This indicates a sustained demand for ARE's properties. The rental rate has also seen an uptick, with a 19.7% increase for the quarter and 18.7% for the year, surpassing the historical average. Financially, ARE maintains a strong liquidity position, with net debt and preferred stock to adjusted EBITDA ratio of 5.4x and a fixed-charge coverage ratio of 4.8x for Q3 2023, underscoring the company's strategic financial management.

Moreover, the company reports substantial external growth and investments in real estate, with a strong emphasis on leased value-creation projects. ARE's incremental net operating income is set to increase by $120 million, commencing in 2023, including $39 million from Q3 2023 and driving future annual incremental net operating income of $580 million. In the first half of 2023, the company placed into service properties that are 100% leased/negotiating, representing 840,587 RSF. Financially, ARE has a strong balance sheet as of September 30, 2023, with a total market capitalization of $28.3 billion and total equity capitalization of $17.1 billion, ranking in the top 10% among all publicly traded U.S. REITs.

Overall, ARE's financial performance in Q3 2023 presents a complex but promising picture. Despite a noticeable drop in net income, the company has shown resilience through increased total revenues and funds from operations, indicating robust operational efficiency. The positive trends in leasing activity, occupancy rates, and rental increases reflect a strong market position and sustained demand for ARE's properties. With a solid balance sheet, substantial investments in value-creation projects, and strategic financial management, ARE appears well-positioned for sustained growth and profitability in the evolving real estate market.

Examining the Rebound from Support Junction

The technical analysis of ARE's stock demonstrates a robust upward trend, as evident in the monthly chart. Notably, since reaching the low point of $19.58 after the Great Recession in 2009, ARE's stock price has steadily risen, culminating in an all-time high of $210.93 in 2021. This significant growth was due to a combination of factors. Primarily, the company benefited from the burgeoning biotech and life sciences sectors, which have shown exponential growth and resilience, particularly highlighted during the COVID-19 pandemic. As a REIT specializing in leasing office and laboratory space to science and technology companies, ARE was perfectly positioned to capitalize on the increased demand for such specialized real estate. Additionally, low interest rates post-2009 made real estate investments more attractive, aiding in appreciating ARE. The firm's strategic locations in key innovation hubs, strong financial management, and a growing portfolio of high-quality tenants further bolstered investor confidence, driving the stock to record highs.

Significant volatility and sharp fluctuations characterized the surge in ARE's stock to its record highs. This was reflected in the highly overbought indicators on technical charts, leading to a corrective drop in the stock price towards a crucial support level, identified by the intersection of the red and blue trend lines at $90.73. This red trend line has been a reliable support throughout the impressive rally from the 2009 lows, underscored by the red circles on the chart. A substantial correction occurred in 2022, bringing the stock to the long-term support level of $90.73 in October 2023.

However, in November 2023, the stock experienced a strong rebound from this level, marking a significant key reversal at this support junction. This key reversal in November suggests the formation of a long-term bottom at this support and hints at an impending market rally. Additionally, the RSI is recovering from levels not seen since the 2009 lows. This robust rebound from the support junction signals a likely upward trajectory for the stock price.

Investor Consideration

To delve deeper into the bullish perspective, the weekly chart illustrates the price's bounce from the long-term support level. The blue trendline further reinforces this support. The significant weekly candle observed in the past week suggests an upward momentum for the price. Moreover, the RSI has recovered from its low points and is now advancing above the mid-level, indicating potential for further gains.

On the daily chart, there's an evident formation of an inverted head and shoulders pattern, with the head at $90.73 and the shoulders at $95.21 and $93.17. This pattern was disrupted by a substantial price movement last week, which appears to establish a base for the potential upward price trend. However, in the short term, the RSI is indicating overbought conditions. Since the price has reached the long-term support level, investors may consider initiating long positions at the current price, anticipating a continuation of the upward momentum.

Market Risk

The reported downturn in net income for common stockholders highlights a risk of further financial instability if the market conditions deteriorate. The technical analysis of ARE’s stock reveals its volatility and the potential for significant fluctuations. While the stock has shown a strong recovery trend since the 2009 low, reaching an all-time high in 2021, it has also experienced sharp corrections, most notably in 2022, dropping to a long-term support level of $90.73. This volatility significantly introduces a risk for investors if the stock deviates from its expected upward trajectory following the November 2023 key reversal.

The overbought conditions indicated by the RSI on the daily chart also suggest a potential short-term pullback, which could impact investor sentiment and stock performance. Furthermore, the market's response to the stock's rebound from the support level and its future direction remain uncertain, potentially leading to increased risk for short-term traders.

While ARE’s position as a leading REIT with a diversified client base in the biotech and life sciences sectors is a strength, it also exposes the company to industry-specific risks. The company's performance is closely tied to the health of these sectors. Any downturns or slowdowns in the biotech and life sciences industries could significantly impact ARE's leasing activities and revenue streams.

Bottom Line

In conclusion, ARE's performance in Q3 2023 paints a complex but ultimately encouraging picture of a company navigating the ebbs and flows of the real estate market with strategic insight. Despite a downturn in net income, the company demonstrated substantial growth in total revenues and funds from operations, underlining its operational resilience and efficiency. The increase in leasing activity, coupled with solid occupancy rates and rental growth, reflects ARE's robust position in the market and the ongoing demand for its properties. Financially, ARE maintains a solid footing, with a strong balance sheet and strategic investments for long-term value creation. These factors position ARE well for continued growth and profitability in a dynamically evolving real estate landscape.

From a technical perspective, ARE's stock presents a potentially lucrative opportunity for investors. The stock's rebound from a significant long-term support junction suggests a possible upward trajectory, backed by patterns seen in various technical charts. The notable key reversal in November 2023 underscores the price strength. Investors may consider buying ARE at its present levels in anticipation of potential price increases.

For further details see: